TreeWAS – Variant ID: rs13385025

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E10 Insulin-dependent diabetes mellitus	0.403	0.597	0.000
E10-E14 Diabetes mellitus	0.393	0.607	0.000
E11 Non-insulin-dependent diabetes mellitus	0.382	0.618	0.000
E10.9 Without complications	0.381	0.619	0.000
E14 Unspecified diabetes mellitus	0.370	0.630	0.000
E10.3 With ophthalmic complications	0.364	0.636	0.000
E14.3 With ophthalmic complications	0.355	0.645	0.000
E10.4 With neurological complications	0.348	0.652	0.000
E10.5 With peripheral circulatory complications	0.343	0.657	0.000
E10.2 With renal complications	0.340	0.660	0.000
E11.5 With peripheral circulatory complications	0.339	0.661	0.000
E11.4 With neurological complications	0.316	0.684	0.000
E11.2 With renal complications	0.315	0.685	0.000
E10.0 With coma	0.314	0.686	0.000
E14.4 With neurological complications	0.312	0.688	0.000
E11.8 With unspecified complications	0.303	0.697	0.000
E11.1 With ketoacidosis	0.301	0.699	0.000
E10.1 With ketoacidosis	0.294	0.705	0.000
E14.8 With unspecified complications	0.294	0.706	0.000
E10.7 With multiple complications	0.289	0.711	0.000
E10.6 With other specified complications	0.288	0.712	0.000
E11.0 With coma	0.288	0.712	0.000
E11.9 Without complications	0.287	0.713	0.000
E11.6 With other specified complications	0.285	0.715	0.000
E10.8 With unspecified complications	0.284	0.715	0.000
E14.5 With peripheral circulatory complications	0.284	0.716	0.000
E13 Other specified diabetes mellitus	0.282	0.718	0.000
E12 Malnutrition-related diabetes mellitus	0.282	0.718	0.000
E11.7 With multiple complications	0.274	0.726	0.000
E14.7 With multiple complications	0.266	0.734	0.000
E14.6 With other specified complications	0.266	0.734	0.000
E14.2 Withrenal complications	0.266	0.734	0.000
E14.1 With ketoacidosis	0.266	0.734	0.000
E14.0 With coma	0.266	0.734	0.000
E11.3 With ophthalmic complications	0.235	0.765	0.000
E13.3 With ophthalmic complications	0.227	0.773	0.000
E13.8 With unspecified complications	0.202	0.798	0.000
E13.7 With multiple complications	0.202	0.798	0.000
E13.6 With other specified complications	0.202	0.798	0.000
E13.5 With peripheral circulatory complications	0.202	0.798	0.000
E13.4 With neurological complications	0.202	0.798	0.000
E13.2 With renal complications	0.202	0.798	0.000
E13.1 With ketoacidosis	0.202	0.798	0.000
E13.0 With coma	0.202	0.798	0.000
E12.9 Without complications	0.202	0.798	0.000
E12.8 With unspecified complications	0.202	0.798	0.000
E12.7 With multiple complications	0.202	0.798	0.000
E12.6 With other specified complications	0.202	0.798	0.000
E12.5 With peripheral circulatory complications	0.202	0.798	0.000
E12.4 With neurological complications	0.202	0.798	0.000
E12.3 With ophthalmic complications	0.202	0.798	0.000
E12.2 With renal complications	0.202	0.798	0.000
E12.1 With ketoacidosis	0.202	0.798	0.000
E12.0 With coma	0.202	0.798	0.000
E13.9 Without complications	0.167	0.833	0.000
E14.9 Without complications	0.051	0.949	0.000
Chapter IV Endocrine, nutritional and metabolic diseases	0.027	0.973	0.000
E00-E07 Disorders of thyroid gland	0.025	0.975	0.000
E04.9 Non-toxic goitre, unspecified	0.024	0.976	0.000
E04 Other non-toxic goitre	0.024	0.976	0.000
E07 Other disorders of thyroid	0.022	0.978	0.000
E06 Thyroiditis	0.021	0.979	0.000
E07.9 Disorder of thyroid, unspecified	0.021	0.979	0.000
E04.0 Non-toxic diffuse goitre	0.021	0.979	0.000
E40-E46 Malnutrition	0.018	0.982	0.000
E06.3 Autoimmune thyroiditis	0.018	0.982	0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions	0.018	0.982	0.000
E00 Congenital iodine-deficiency syndrome	0.018	0.982	0.000
E02 Subclinical iodine-deficiency hypothyroidism	0.018	0.982	0.000
E21.0 Primary hyperparathyroidism	0.018	0.982	0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.017	0.983	0.000
E04.8 Other specified non-toxic goitre	0.017	0.983	0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.017	0.983	0.000
E20-E35 Disorders of other endocrine glands	0.017	0.983	0.000
E07.1 Dyshormogenetic goitre	0.016	0.984	0.000
E07.0 Hypersecretion of calcitonin	0.016	0.984	0.000
E07.8 Other specified disorders of thyroid	0.015	0.985	0.000
E06.5 Other chronic thyroiditis	0.015	0.985	0.000
E06.4 Drug-induced thyroiditis	0.015	0.985	0.000
E06.2 Chronic thyroiditis with transient thyrotoxicosis	0.015	0.985	0.000
E06.1 Subacute thyroiditis	0.015	0.985	0.000
E06.0 Acute thyroiditis	0.015	0.985	0.000
E21.5 Disorder of parathyroid gland, unspecified	0.015	0.985	0.000
E06.9 Thyroiditis, unspecified	0.014	0.986	0.000
E05 Thyrotoxicosis [hyperthyroidism]	0.014	0.986	0.000
E44 Protein-energy malnutrition of moderate and mild degree	0.013	0.986	0.000
E45 Retarded development following protein-energy malnutrition	0.013	0.986	0.000
E43 Unspecified severe protein-energy malnutrition	0.013	0.986	0.000
E42 Marasmic kwashiorkor	0.013	0.986	0.000
E41 Nutritional marasmus	0.013	0.986	0.000
E40 Kwashiorkor	0.013	0.986	0.000
E00.9 Congenital iodine-deficiency syndrome, unspecified	0.013	0.987	0.000
E00.2 Congenital iodine-deficiency syndrome, mixed type	0.013	0.987	0.000
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type	0.013	0.987	0.000
E00.0 Congenital iodine-deficiency syndrome, neurological type	0.013	0.987	0.000
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions	0.013	0.987	0.000
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified	0.013	0.987	0.000
E01.1 Iodine-deficiency-related multinodular (endemic) goitre	0.013	0.987	0.000
E01.0 Iodine-deficiency-related diffuse (endemic) goitre	0.013	0.987	0.000
E65-E68 Obesity and other hyperalimentation	0.013	0.987	0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.013	0.987	0.000
E34 Other endocrine disorders	0.013	0.987	0.000
E23 Hypofunction and other disorders of pituitary gland	0.013	0.987	0.000
E21.4 Other specified disorders of parathyroid gland	0.012	0.987	0.000
E21.2 Other hyperparathyroidism	0.012	0.987	0.000
E15 Nondiabetic hypoglycaemic coma	0.012	0.987	0.000
E35 Disorders of endocrine glands in diseases classified elsewhere	0.012	0.988	0.000
E32 Diseases of thymus	0.012	0.988	0.000
E31 Polyglandular dysfunction	0.012	0.988	0.000
E30 Disorders of puberty, not elsewhere classified	0.012	0.988	0.000
E25 Adrenogenital disorders	0.012	0.988	0.000
K21.0 Gastro-oesophageal reflux disease with oesophagitis	0.012	0.988	0.000
E46 Unspecified protein-energy malnutrition	0.012	0.988	0.000
E24 Cushing's syndrome	0.012	0.988	0.000
E04.1 Non-toxic single thyroid nodule	0.012	0.988	0.000
E26 Hyperaldosteronism	0.011	0.988	0.000
E20 Hypoparathyroidism	0.011	0.988	0.000
E28 Ovarian dysfunction	0.011	0.988	0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre	0.011	0.989	0.000
E29 Testicular dysfunction	0.011	0.989	0.000
E50-E64 Other nutritional deficiencies	0.008	0.989	0.003
E23.2 Diabetes insipidus	0.011	0.989	0.000
E05.8 Other thyrotoxicosis	0.010	0.989	0.000
E05.5 Thyroid crisis or storm	0.010	0.990	0.000
E05.4 Thyrotoxicosis factitia	0.010	0.990	0.000
E05.3 Thyrotoxicosis from ectopic thyroid tissue	0.010	0.990	0.000
E05.1 Thyrotoxicosis with toxic single thyroid nodule	0.010	0.990	0.000
E44.1 Mild protein-energy malnutrition	0.010	0.990	0.000
E44.0 Moderate protein-energy malnutrition	0.010	0.990	0.000
E34.8 Other specified endocrine disorders	0.010	0.990	0.000
E03 Other hypothyroidism	0.010	0.990	0.000
E16 Other disorders of pancreatic internal secretion	0.010	0.990	0.000
E34.9 Endocrine disorder, unspecified	0.010	0.990	0.000
E67 Other hyperalimentation	0.010	0.990	0.000
E68 Sequelae of hyperalimentation	0.010	0.990	0.000
E34.0 Carcinoid syndrome	0.009	0.990	0.000
E34.5 Androgen resistance syndrome	0.009	0.990	0.000
E34.4 Constitutional tall stature	0.009	0.990	0.000
E34.3 Short stature, not elsewhere classified	0.009	0.990	0.000
E34.2 Ectopic hormone secretion, not elsewhere classified	0.009	0.990	0.000
E34.1 Other hypersecretion of intestinal hormones	0.009	0.990	0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified	0.009	0.991	0.000
E23.1 Drug-induced hypopituitarism	0.009	0.991	0.000
E24.0 Pituitary-dependent Cushing's disease	0.009	0.991	0.000
E23.7 Disorder of pituitary gland, unspecified	0.009	0.991	0.000
E25.9 Adrenogenital disorder, unspecified	0.009	0.991	0.000
E25.8 Other adrenogenital disorders	0.009	0.991	0.000
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency	0.009	0.991	0.000
E30.9 Disorder of puberty, unspecified	0.009	0.991	0.000
E30.8 Other disorders of puberty	0.009	0.991	0.000
E30.1 Precocious puberty	0.009	0.991	0.000
E30.0 Delayed puberty	0.009	0.991	0.000
E31.9 Polyglandular dysfunction, unspecified	0.009	0.991	0.000
E31.8 Other polyglandular dysfunction	0.009	0.991	0.000
E31.1 Polyglandular hyperfunction	0.009	0.991	0.000
E31.0 Autoimmune polyglandular failure	0.009	0.991	0.000
E32.9 Disease of thymus, unspecified	0.009	0.991	0.000
E32.8 Other diseases of thymus	0.009	0.991	0.000
E32.1 Abscess of thymus	0.009	0.991	0.000
E32.0 Persistent hyperplasia of thymus	0.009	0.991	0.000
E35.8 Disorders of other endocrine glands in diseases classified elsewhere	0.009	0.991	0.000
E35.1 Disorders of adrenal glands in diseases classified elsewhere	0.009	0.991	0.000
E35.0 Disorders of thyroid gland in diseases classified elsewhere	0.009	0.991	0.000
E21.3 Hyperparathyroidism, unspecified	0.009	0.991	0.000
E24.8 Other Cushing's syndrome	0.009	0.991	0.000
E24.4 Alcohol-induced pseudo-Cushing's syndrome	0.009	0.991	0.000
E24.3 Ectopic ACTH syndrome	0.009	0.991	0.000
E24.2 Drug-induced Cushing's syndrome	0.009	0.991	0.000
E24.1 Nelson's syndrome	0.009	0.991	0.000
E23.6 Other disorders of pituitary gland	0.009	0.991	0.000
E05.0 Thyrotoxicosis with diffuse goitre	0.009	0.991	0.000
E26.9 Hyperaldosteronism, unspecified	0.008	0.991	0.000
E26.8 Other hyperaldosteronism	0.008	0.991	0.000
E26.1 Secondary hyperaldosteronism	0.008	0.991	0.000
E20.8 Other hypoparathyroidism	0.008	0.991	0.000
E20.1 Pseudohypoparathyroidism	0.008	0.991	0.000
E20.0 Idiopathic hypoparathyroidism	0.008	0.991	0.000
E28.9 Ovarian dysfunction, unspecified	0.008	0.991	0.000
E28.8 Other ovarian dysfunction	0.008	0.991	0.000
E28.1 Androgen excess	0.008	0.991	0.000
E28.0 Oestrogen excess	0.008	0.991	0.000
E28.2 Polycystic ovarian syndrome	0.008	0.992	0.000
E65 Localised adiposity	0.008	0.992	0.000
E29.9 Testicular dysfunction, unspecified	0.008	0.992	0.000
E29.8 Other testicular dysfunction	0.008	0.992	0.000
E29.0 Testicular hyperfunction	0.008	0.992	0.000
E64 Sequelae of malnutrition and other nutritional deficiencies	0.006	0.992	0.002
E63 Other nutritional deficiencies	0.006	0.992	0.002
E56 Other vitamin deficiencies	0.006	0.992	0.002
E51 Thiamine deficiency	0.006	0.992	0.002
E50 Vitamin A deficiency	0.006	0.992	0.002
E60 Dietary zinc deficiency	0.006	0.992	0.002
E59 Dietary selenium deficiency	0.006	0.992	0.002
E58 Dietary calcium deficiency	0.006	0.992	0.002
E54 Ascorbic acid deficiency	0.006	0.992	0.002
E52 Niacin deficiency [pellagra]	0.006	0.992	0.002
E24.9 Cushing's syndrome, unspecified	0.008	0.992	0.000
E22 Hyperfunction of pituitary gland	0.008	0.992	0.000
E23.0 Hypopituitarism	0.008	0.992	0.000
E26.0 Primary hyperaldosteronism	0.008	0.992	0.000
E55 Vitamin D deficiency	0.004	0.992	0.004
E28.3 Primary ovarian failure	0.007	0.992	0.000
E20.9 Hypoparathyroidism, unspecified	0.007	0.992	0.000
E61 Deficiency of other nutrient elements	0.004	0.992	0.003
E04.2 Non-toxic multinodular goitre	0.007	0.992	0.000
E03.8 Other specified hypothyroidism	0.007	0.993	0.000
E03.5 Myxoedema coma	0.007	0.993	0.000
E03.4 Atrophy of thyroid (acquired)	0.007	0.993	0.000
E03.3 Postinfectious hypothyroidism	0.007	0.993	0.000
E03.1 Congenital hypothyroidism without goitre	0.007	0.993	0.000
E03.0 Congenital hypothyroidism with diffuse goitre	0.007	0.993	0.000
E16.9 Disorder of pancreatic internal secretion, unspecified	0.007	0.993	0.000
E16.8 Other specified disorders of pancreatic internal secretion	0.007	0.993	0.000
E16.4 Abnormal secretion of gastrin	0.007	0.993	0.000
E16.3 Increased secretion of glucagon	0.007	0.993	0.000
E16.0 Drug-induced hypoglycaemia without coma	0.007	0.993	0.000
H21.8 Other specified disorders of iris and ciliary body	0.007	0.993	0.000
E67.8 Other specified hyperalimentation	0.007	0.993	0.000
E67.3 Hypervitaminosis D	0.007	0.993	0.000
E67.2 Megavitamin-B6 syndrome	0.007	0.993	0.000
E67.1 Hypercarotenaemia	0.007	0.993	0.000
E67.0 Hypervitaminosis A	0.007	0.993	0.000
E29.1 Testicular hypofunction	0.007	0.993	0.000
E16.1 Other hypoglycaemia	0.007	0.993	0.000
I60.2 Subarachnoid haemorrhage from anterior communicating artery	0.007	0.993	0.000
I12.0 Hypertensive renal disease with renal failure	0.007	0.993	0.000
D47.3 Essential (haemorrhagic) thrombocythaemia	0.006	0.993	0.000
E03.2 Hypothyroidism due to medicaments and other exogenous substances	0.006	0.994	0.000
L40.9 Psoriasis, unspecified	0.000	0.994	0.006
E53 Deficiency of other B group vitamins	0.005	0.994	0.002
E50.9 Vitamin A deficiency, unspecified	0.005	0.994	0.002
E50.8 Other manifestations of vitamin A deficiency	0.005	0.994	0.002
E50.7 Other ocular manifestations of vitamin A deficiency	0.005	0.994	0.002
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea	0.005	0.994	0.002
E50.5 Vitamin A deficiency with night blindness	0.005	0.994	0.002
E50.4 Vitamin A deficiency with keratomalacia	0.005	0.994	0.002
E50.3 Vitamin A deficiency with corneal ulceration and xerosis	0.005	0.994	0.002
E50.2 Vitamin A deficiency with corneal xerosis	0.005	0.994	0.002
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis	0.005	0.994	0.002
E50.0 Vitamin A deficiency with conjunctival xerosis	0.005	0.994	0.002
E51.9 Thiamine deficiency, unspecified	0.005	0.994	0.002
E51.8 Other manifestations of thiamine deficiency	0.005	0.994	0.002
E51.2 Wernicke's encephalopathy	0.005	0.994	0.002
E51.1 Beriberi	0.005	0.994	0.002
E56.9 Vitamin deficiency, unspecified	0.005	0.994	0.002
E56.8 Deficiency of other vitamins	0.005	0.994	0.002
E56.1 Deficiency of vitamin K	0.005	0.994	0.002
E56.0 Deficiency of vitamin E	0.005	0.994	0.002
E63.9 Nutritional deficiency, unspecified	0.005	0.994	0.002
E63.8 Other specified nutritional deficiencies	0.005	0.994	0.002
E63.1 Imbalance of constituents of food intake	0.005	0.994	0.002
E63.0 Essential fatty acid [EFA] deficiency	0.005	0.994	0.002
E64.9 Sequelae of unspecified nutritional deficiency	0.005	0.994	0.002
E64.8 Sequelae of other nutritional deficiencies	0.005	0.994	0.002
E64.3 Sequelae of rickets	0.005	0.994	0.002
E64.2 Sequelae of vitamin C deficiency	0.005	0.994	0.002
E64.1 Sequelae of vitamin A deficiency	0.005	0.994	0.002
E64.0 Sequelae of protein-energy malnutrition	0.005	0.994	0.002
E22.9 Hyperfunction of pituitary gland, unspecified	0.006	0.994	0.000
E22.8 Other hyperfunction of pituitary gland	0.006	0.994	0.000
E55.9 Vitamin D deficiency, unspecified	0.001	0.994	0.006
E55.0 Rickets, active	0.003	0.994	0.003
E66 Obesity	0.006	0.994	0.000
H21 Other disorders of iris and ciliary body	0.006	0.994	0.000
E61.9 Deficiency of nutrient element, unspecified	0.003	0.994	0.003
E61.8 Deficiency of other specified nutrient elements	0.003	0.994	0.003
E61.7 Deficiency of multiple nutrient elements	0.003	0.994	0.003
E61.6 Vanadium deficiency	0.003	0.994	0.003
E61.5 Molybdenum deficiency	0.003	0.994	0.003
E61.4 Chromium deficiency	0.003	0.994	0.003
E61.3 Manganese deficiency	0.003	0.994	0.003
E61.2 Magnesium deficiency	0.003	0.994	0.003
E61.0 Copper deficiency	0.003	0.994	0.003
E22.0 Acromegaly and pituitary gigantism	0.005	0.994	0.000
E16.2 Hypoglycaemia, unspecified	0.005	0.994	0.000
M06.9 Rheumatoid arthritis, unspecified	0.005	0.995	0.000
E61.1 Iron deficiency	0.001	0.995	0.004
H21.5 Other adhesions and disruptions of iris and ciliary body	0.005	0.995	0.000
E27 Other disorders of adrenal gland	0.004	0.995	0.001
C61 Malignant neoplasm of prostate	0.005	0.995	0.000
H21.0 Hyphaema	0.005	0.995	0.000
I60 Subarachnoid haemorrhage	0.005	0.995	0.000
M06.0 Seronegative rheumatoid arthritis	0.005	0.995	0.000
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)	0.005	0.995	0.000
M06.00 Seronegative rheumatoid arthritis (Multiple sites)	0.005	0.995	0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone	0.005	0.995	0.000
E22.1 Hyperprolactinaemia	0.004	0.995	0.000
M06.94 Rheumatoid arthritis, unspecified (Hand)	0.005	0.995	0.000
E53.1 Pyridoxine deficiency	0.004	0.995	0.001
E53.0 Riboflavin deficiency	0.004	0.995	0.001
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)	0.005	0.995	0.000
I60.4 Subarachnoid haemorrhage from basilar artery	0.005	0.995	0.000
M06 Other rheumatoid arthritis	0.005	0.995	0.000
M54.22 Cervicalgia (Cervical region)	0.005	0.995	0.000
E53.9 Vitamin B deficiency, unspecified	0.003	0.995	0.001
M06.92 Rheumatoid arthritis, unspecified (Upper arm)	0.005	0.995	0.000
I60.9 Subarachnoid haemorrhage, unspecified	0.005	0.995	0.000
E66.8 Other obesity	0.005	0.995	0.000
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.004	0.996	0.000
E66.1 Drug-induced obesity	0.004	0.996	0.000
E66.0 Obesity due to excess calories	0.004	0.996	0.000
H21.9 Disorder of iris and ciliary body, unspecified	0.004	0.996	0.000
H21.4 Pupillary membranes	0.004	0.996	0.000
H21.3 Cyst of iris, ciliary body and anterior chamber	0.004	0.996	0.000
H21.2 Degeneration of iris and ciliary body	0.004	0.996	0.000
M06.09 Seronegative rheumatoid arthritis (Site unspecified)	0.004	0.996	0.000
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.004	0.996	0.000
D47.1 Chronic myeloproliferative disease	0.004	0.996	0.000
M06.4 Inflammatory polyarthropathy	0.004	0.996	0.000
N28.8 Other specified disorders of kidney and ureter	0.004	0.996	0.000
E66.2 Extreme obesity with alveolar hypoventilation	0.004	0.996	0.000
H21.1 Other vascular disorders of iris and ciliary body	0.004	0.996	0.000
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)	0.004	0.996	0.000
M06.3 Rheumatoid nodule	0.004	0.996	0.000
E27.9 Disorder of adrenal gland, unspecified	0.003	0.996	0.001
I60.1 Subarachnoid haemorrhage from middle cerebral artery	0.004	0.996	0.000
E27.5 Adrenomedullary hyperfunction	0.003	0.996	0.001
E27.3 Drug-induced adrenocortical insufficiency	0.003	0.996	0.001
E27.0 Other adrenocortical overactivity	0.003	0.996	0.001
I60.6 Subarachnoid haemorrhage from other intracranial arteries	0.004	0.996	0.000
I60.7 Subarachnoid haemorrhage from intracranial artery, unspecified	0.004	0.996	0.000
I60.5 Subarachnoid haemorrhage from vertebral artery	0.004	0.996	0.000
I60.0 Subarachnoid haemorrhage from carotid siphon and bifurcation	0.004	0.996	0.000
M06.08 Seronegative rheumatoid arthritis (Other)	0.004	0.996	0.000
M06.07 Seronegative rheumatoid arthritis (Ankle and foot)	0.004	0.996	0.000
M06.06 Seronegative rheumatoid arthritis (Lower leg)	0.004	0.996	0.000
M06.05 Seronegative rheumatoid arthritis (Pelvic region and thigh)	0.004	0.996	0.000
M06.04 Seronegative rheumatoid arthritis (Hand)	0.004	0.996	0.000
M06.03 Seronegative rheumatoid arthritis (Forearm)	0.004	0.996	0.000
M06.02 Seronegative rheumatoid arthritis (Upper arm)	0.004	0.996	0.000
M06.01 Seronegative rheumatoid arthritis (Shoulder region)	0.004	0.996	0.000
M06.98 Rheumatoid arthritis, unspecified (Other)	0.004	0.996	0.000
M06.96 Rheumatoid arthritis, unspecified (Lower leg)	0.004	0.996	0.000
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)	0.004	0.996	0.000
I60.3 Subarachnoid haemorrhage from posterior communicating artery	0.004	0.996	0.000
K29.0 Acute haemorrhagic gastritis	0.004	0.996	0.000
M06.8 Other specified rheumatoid arthritis	0.004	0.996	0.000
M06.2 Rheumatoid bursitis	0.004	0.996	0.000
M06.1 Adult-onset Still's disease	0.004	0.996	0.000
M06.40 Inflammatory polyarthropathy (Multiple sites)	0.004	0.996	0.000
M06.93 Rheumatoid arthritis, unspecified (Forearm)	0.004	0.996	0.000
E27.2 Addisonian crisis	0.003	0.996	0.001
E27.8 Other specified disorders of adrenal gland	0.003	0.996	0.001
I12 Hypertensive renal disease	0.003	0.996	0.000
M06.49 Inflammatory polyarthropathy (Site unspecified)	0.003	0.997	0.000
D47.7 Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.003	0.997	0.000
D47.5 Chronic eosinophilic leukaemia [hypereosinophilic syndrome]	0.003	0.997	0.000
D47.0 Histiocytic and mast cell tumours of uncertain and unknown behaviour	0.003	0.997	0.000
M06.32 Rheumatoid nodule (Upper arm)	0.003	0.997	0.000
R93.2 Abnormal findings on diagnostic imaging of liver and biliary tract	0.003	0.997	0.000
D47.4 Osteomyelofibrosis	0.003	0.997	0.000
M06.48 Inflammatory polyarthropathy (Other)	0.003	0.997	0.000
M06.47 Inflammatory polyarthropathy (Ankle and foot)	0.003	0.997	0.000
M06.46 Inflammatory polyarthropathy (Lower leg)	0.003	0.997	0.000
M06.45 Inflammatory polyarthropathy (Pelvic region and thigh)	0.003	0.997	0.000
M06.44 Inflammatory polyarthropathy (Hand)	0.003	0.997	0.000
M06.43 Inflammatory polyarthropathy (Forearm)	0.003	0.997	0.000
M06.42 Inflammatory polyarthropathy (Upper arm)	0.003	0.997	0.000
M06.41 Inflammatory polyarthropathy (Shoulder region)	0.003	0.997	0.000
I73.9 Peripheral vascular disease, unspecified	0.003	0.997	0.000
D47.9 Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified	0.003	0.997	0.000
R61.9 Hyperhidrosis, unspecified	0.003	0.997	0.000
K91.4 Colostomy and enterostomy malfunction	0.000	0.997	0.003
E05.9 Thyrotoxicosis, unspecified	0.003	0.997	0.000
M06.39 Rheumatoid nodule (Site unspecified)	0.003	0.997	0.000
M06.38 Rheumatoid nodule (Other)	0.003	0.997	0.000
M06.36 Rheumatoid nodule (Lower leg)	0.003	0.997	0.000
M06.35 Rheumatoid nodule (Pelvic region and thigh)	0.003	0.997	0.000
M06.33 Rheumatoid nodule (Forearm)	0.003	0.997	0.000
M06.31 Rheumatoid nodule (Shoulder region)	0.003	0.997	0.000
M06.30 Rheumatoid nodule (Multiple sites)	0.003	0.997	0.000
M06.37 Rheumatoid nodule (Ankle and foot)	0.003	0.997	0.000
M06.34 Rheumatoid nodule (Hand)	0.003	0.997	0.000
D47.2 Monoclonal gammopathy	0.003	0.997	0.000
I60.8 Other subarachnoid haemorrhage	0.003	0.997	0.000
I12.9 Hypertensive renal disease without renal failure	0.003	0.997	0.000
M06.19 Adult-onset Still's disease (Site unspecified)	0.003	0.997	0.000
M06.18 Adult-onset Still's disease (Other)	0.003	0.997	0.000
M06.17 Adult-onset Still's disease (Ankle and foot)	0.003	0.997	0.000
M06.16 Adult-onset Still's disease (Lower leg)	0.003	0.997	0.000
M06.15 Adult-onset Still's disease (Pelvic region and thigh)	0.003	0.997	0.000
M06.14 Adult-onset Still's disease (Hand)	0.003	0.997	0.000
M06.13 Adult-onset Still's disease (Forearm)	0.003	0.997	0.000
M06.12 Adult-onset Still's disease (Upper arm)	0.003	0.997	0.000
M06.11 Adult-onset Still's disease (Shoulder region)	0.003	0.997	0.000
M06.10 Adult-onset Still's disease (Multiple sites)	0.003	0.997	0.000
M06.29 Rheumatoid bursitis (Site unspecified)	0.003	0.997	0.000
M06.28 Rheumatoid bursitis (Other)	0.003	0.997	0.000
M06.27 Rheumatoid bursitis (Ankle and foot)	0.003	0.997	0.000
M06.26 Rheumatoid bursitis (Lower leg)	0.003	0.997	0.000
M06.25 Rheumatoid bursitis (Pelvic region and thigh)	0.003	0.997	0.000
M06.24 Rheumatoid bursitis (Hand)	0.003	0.997	0.000
M06.23 Rheumatoid bursitis (Forearm)	0.003	0.997	0.000
M06.22 Rheumatoid bursitis (Upper arm)	0.003	0.997	0.000
M06.21 Rheumatoid bursitis (Shoulder region)	0.003	0.997	0.000
M06.20 Rheumatoid bursitis (Multiple sites)	0.003	0.997	0.000
M06.89 Other specified rheumatoid arthritis (Site unspecified)	0.003	0.997	0.000
M06.88 Other specified rheumatoid arthritis (Other)	0.003	0.997	0.000
M06.87 Other specified rheumatoid arthritis (Ankle and foot)	0.003	0.997	0.000
M06.86 Other specified rheumatoid arthritis (Lower leg)	0.003	0.997	0.000
M06.85 Other specified rheumatoid arthritis (Pelvic region and thigh)	0.003	0.997	0.000
M06.84 Other specified rheumatoid arthritis (Hand)	0.003	0.997	0.000
M06.83 Other specified rheumatoid arthritis (Forearm)	0.003	0.997	0.000
M06.82 Other specified rheumatoid arthritis (Upper arm)	0.003	0.997	0.000
M06.81 Other specified rheumatoid arthritis (Shoulder region)	0.003	0.997	0.000
M06.80 Other specified rheumatoid arthritis (Multiple sites)	0.003	0.997	0.000
H15-H22 Disorders of sclera, cornea, iris and ciliary body	0.003	0.997	0.000
M54.2 Cervicalgia	0.003	0.997	0.000
N28.9 Disorder of kidney and ureter, unspecified	0.003	0.997	0.000
E53.8 Deficiency of other specified B group vitamins	0.002	0.997	0.001
S61.8 Open wound of other parts of wrist and hand	0.000	0.997	0.003
D23.6 Skin of upper limb, including shoulder	0.003	0.997	0.000
E85.4 Organ-limited amyloidosis	0.003	0.997	0.000
H65.3 Chronic mucoid otitis media	0.003	0.997	0.000
R47.8 Other and unspecified speech disturbances	0.003	0.997	0.000
E85 Amyloidosis	0.003	0.997	0.000
M54.29 Cervicalgia-Site unspe	0.003	0.997	0.000
E27.4 Other and unspecified adrenocortical insufficiency	0.001	0.997	0.001
E27.1 Primary adrenocortical insufficiency	0.002	0.997	0.001
E70-E90 Metabolic disorders	0.003	0.997	0.000
Q51.3 Bicornate uterus	0.003	0.997	0.000
M79.79 Fibromyalgia (Site unspecified)	0.003	0.997	0.000
I95.1 Orthostatic hypotension	0.003	0.997	0.000
H19 Disorders of sclera and cornea in diseases classified elsewhere	0.003	0.997	0.000
C77.2 Intra-abdominal lymph nodes	0.000	0.997	0.003
H49.0 Third [oculomotor] nerve palsy	0.003	0.997	0.000
R47.0 Dysphasia and aphasia	0.003	0.997	0.000
H16 Keratitis	0.002	0.997	0.000
T11.0 Superficial injury of upper limb, level unspecified	0.002	0.997	0.000
Z49.1 Extracorporeal dialysis	0.003	0.997	0.000
N28 Other disorders of kidney and ureter, not elsewhere classified	0.003	0.997	0.000
H16.9 Keratitis, unspecified	0.002	0.997	0.000
H15 Disorders of sclera	0.002	0.997	0.000
M79.67 Pain in limb (Ankle and foot)	0.003	0.997	0.000
E73 Lactose intolerance	0.002	0.997	0.000
H49 Paralytic strabismus	0.002	0.998	0.000
M54.23 Cervicalgia (Cervicothoracic region)	0.002	0.998	0.000
H81.1 Benign paroxysmal vertigo	0.002	0.998	0.000
E74 Other disorders of carbohydrate metabolism	0.002	0.998	0.000
E85.9 Amyloidosis, unspecified	0.002	0.998	0.000
R93.5 Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum	0.002	0.998	0.000
N19 Unspecified renal failure	0.002	0.998	0.000
Y40.9 Systemic antibiotic, unspecified	0.002	0.998	0.000
R47 Speech disturbances, not elsewhere classified	0.002	0.998	0.000
H52.3 Anisometropia and aniseikonia	0.002	0.998	0.000
H22 Disorders of iris and ciliary body in diseases classified elsewhere	0.002	0.998	0.000
Q51 Congenital malformations of uterus and cervix	0.002	0.998	0.000
M54.28 Cervicalgia-Sacral/sacrococ	0.002	0.998	0.000
M54.27 Cervicalgia-Lumbosacral	0.002	0.998	0.000
M54.26 Cervicalgia-Lumbar	0.002	0.998	0.000
M54.25 Cervicalgia-Thoracolumbar	0.002	0.998	0.000
M54.24 Cervicalgia-Thoracic	0.002	0.998	0.000
M54.21 Cervicalgia (Occipito-atlanto-axial region)	0.002	0.998	0.000
M54.20 Cervicalgia-Mult site	0.002	0.998	0.000
H16.1 Other superficial keratitis without conjunctivitis	0.002	0.998	0.000
D45 Polycythaemia vera	0.002	0.998	0.000
E73.9 Lactose intolerance, unspecified	0.002	0.998	0.000
N18.0 End-stage renal disease	0.002	0.998	0.000
L40 Psoriasis	0.000	0.998	0.002
H19.1 Herpesviral keratitis and keratoconjunctivitis	0.002	0.998	0.000
K21 Gastro-oesophageal reflux disease	0.002	0.998	0.000
E85.8 Other amyloidosis	0.002	0.998	0.000
E85.3 Secondary systemic amyloidosis	0.002	0.998	0.000
E85.2 Heredofamilial amyloidosis, unspecified	0.002	0.998	0.000
E85.1 Neuropathic heredofamilial amyloidosis	0.002	0.998	0.000
E85.0 Nonneuropathic heredofamilial amyloidosis	0.002	0.998	0.000
E74.3 Other disorders of intestinal carbohydrate absorption	0.002	0.998	0.000
Q50.4 Embryonic cyst of Fallopian tube	0.002	0.998	0.000
E80 Disorders of porphyrin and bilirubin metabolism	0.002	0.998	0.000
H49.2 Sixth [abducent] nerve palsy	0.002	0.998	0.000
H65.2 Chronic serous otitis media	0.002	0.998	0.000
N18.4 Chronic kidney disease, stage 4	0.002	0.998	0.000
S82.80 Fractures of other parts of lower leg (closed)	0.000	0.998	0.002
H15.1 Episcleritis	0.002	0.998	0.000
H52.4 Presbyopia	0.002	0.998	0.000
E84 Cystic fibrosis	0.002	0.998	0.000
E79 Disorders of purine and pyrimidine metabolism	0.002	0.998	0.000
E77 Disorders of glycoprotein metabolism	0.002	0.998	0.000
E76 Disorders of glycosaminoglycan metabolism	0.002	0.998	0.000
E75 Disorders of sphingolipid metabolism and other lipid storage disorders	0.002	0.998	0.000
E72 Other disorders of amino-acid metabolism	0.002	0.998	0.000
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism	0.002	0.998	0.000
E70 Disorders of aromatic amino-acid metabolism	0.002	0.998	0.000
E90 Nutritional and metabolic disorders in diseases classified elsewhere	0.002	0.998	0.000
H19.3 Keratitis and keratoconjunctivitis in other diseases classified elsewhere	0.002	0.998	0.000
D37-D48 Neoplasms of uncertain or unknown behaviour	0.002	0.998	0.000
N18 Chronic renal failure	0.002	0.998	0.000
H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction	0.002	0.998	0.000
H65 Nonsuppurative otitis media	0.002	0.998	0.000
H19.8 Other disorders of sclera and cornea in diseases classified elsewhere	0.002	0.998	0.000
H19.2 Keratitis and keratoconjunctivitis in other infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000
H19.0 Scleritis and episcleritis in diseases classified elsewhere	0.002	0.998	0.000
N18.5 Chronic kidney disease, stage 5	0.002	0.998	0.000
Q54 Hypospadias	0.002	0.998	0.000
H16.8 Other keratitis	0.002	0.998	0.000
H16.4 Corneal neovascularisation	0.002	0.998	0.000
H16.3 Interstitial and deep keratitis	0.002	0.998	0.000
H16.2 Keratoconjunctivitis	0.002	0.998	0.000
N39.4 Other specified urinary incontinence	0.002	0.998	0.000
H50 Other strabismus	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations